{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:04:22Z","timestamp":1790748262601,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T00:00:00Z","timestamp":1336521600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.6061\/clinics\/2012(sup01)13","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T17:56:33Z","timestamp":1335290193000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"S1","title":["Genotype-phenotype correlation in multiple endocrine neoplasia type 2"],"prefix":"10.1016","volume":"67","author":[{"given":"Friedhelm","family":"Raue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Frank-Raue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)13_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-010-9320-2","article-title":"Update multiple endocrine neoplasia type 2","volume":"9","author":"Raue","year":"2010","journal-title":"Fam Cancer"},{"issue":"16","key":"10.6061\/clinics\/2012(Sup01)13_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJMoa012915","article-title":"Early malignant progression of hereditary medullary thyroid cancer","volume":"349","author":"Machens","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.6061\/clinics\/2012(Sup01)13_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)13_bib4","first-page":"612","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"key":"10.6061\/clinics\/2012(Sup01)13_bib5","first-page":"82","article-title":"Change in the spectrum of RET mutations diagnosed between 1994 and 2006","volume":"53(5-6)","author":"Frank-Raue","year":"2007","journal-title":"Clin Lab"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)13_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.surg.2008.08.028","article-title":"Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: an exploratory analysis","volume":"144","author":"Brauckhoff","year":"2008","journal-title":"Surgery"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)13_bib7","first-page":"4","article-title":"A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A","volume":"83","author":"Berndt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.6061\/clinics\/2012(Sup01)13_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/jc.2007-1005","article-title":"RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center","volume":"92","author":"Elisei","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)13_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2265.2010.03900.x","article-title":"RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)","volume":"74","author":"Romei","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)13_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1210\/jcem.82.1.3707","article-title":"C cell hyperplasia\/neoplasia","volume":"82","author":"LiVolsi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)13_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1210\/jc.2006-1590","article-title":"Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules","volume":"92","author":"Costante","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)13_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/jc.2008-2403","article-title":"Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults","volume":"94","author":"Doyle","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)13_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/jcem.85.2.6556","article-title":"Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC)","volume":"85","author":"Cohen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)13_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.surg.2007.09.013","article-title":"Pheochromocytoma penetrance varies by RET mutation in MEN 2A","volume":"142","author":"Quayle","year":"2007","journal-title":"Surgery"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)13_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s002689900123","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs a Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons","volume":"20","author":"Kraimps","year":"1996","journal-title":"World J Surg"},{"issue":"4","key":"10.6061\/clinics\/2012(Sup01)13_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 2A","volume":"238","author":"Raue","year":"1995","journal-title":"J Intern Med"},{"issue":"6428","key":"10.6061\/clinics\/2012(Sup01)13_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)13_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.6061\/clinics\/2012(Sup01)13_bib19","first-page":"8","article-title":"Molecular advances in medullary thyroid cancer diagnostics","volume":"370(1-2)","author":"Hubner","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"6461","key":"10.6061\/clinics\/2012(Sup01)13_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/367378a0","article-title":"Mutations of the RET proto-oncogene in Hirschsprung's disease","volume":"367","author":"Edery","year":"1994","journal-title":"Nature"},{"issue":"19","key":"10.6061\/clinics\/2012(Sup01)13_bib21","first-page":"9","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2","volume":"276","author":"Eng","year":"1996","journal-title":"International RET mutation consortium analysis. JAMA"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)13_bib22","first-page":"3","article-title":"Mutations of the RET protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype","volume":"81","author":"Frank-Raue","year":"1996","journal-title":"German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)13_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/0008-5472.CAN-05-2995","article-title":"Polymorphisms in RET and its coreceptors and ligands as genetic modifiers of multiple endocrine neoplasia type 2A","volume":"66","author":"Lesueur","year":"2006","journal-title":"Cancer Res"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)13_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2265.2008.03230.x","article-title":"Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma","volume":"69","author":"Cardot-Bauters","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)13_bib25","first-page":"8","article-title":"Genotype-phenotype relationship in multiple endocrine neoplasia type 2","volume":"8","author":"Raue","year":"2009","journal-title":"Implications for clinical management. Hormones (Athens)"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)13_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1530\/EJE-07-0817","article-title":"Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma","volume":"158","author":"Colombo-Benkmann","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)13_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.2008.03215.x","article-title":"Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791","volume":"69","author":"Frank-Raue","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)13_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12020-009-9242-7","article-title":"RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest","volume":"36","author":"Vaclavikova","year":"2009","journal-title":"Endocrine"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)13_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/jc.2009-1728","article-title":"Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome","volume":"95","author":"Erlic","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)13_bib30","doi-asserted-by":"crossref","unstructured":"Crockett DK, Piccolo SR, Ridge PG, Margraf RL, Lyon E, Williams MS, et al. Predicting phenotypic severity of uncertain gene variants in the RET proto-oncogene. PLoS One 6(3): e18380","DOI":"10.1371\/journal.pone.0018380"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)13_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/EJE-08-0854","article-title":"Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B","volume":"160","author":"Zenaty","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)13_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1677\/ERC-08-0096","article-title":"Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10","volume":"16","author":"Machens","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)13_bib33","first-page":"8","article-title":"Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10","volume":"32","author":"Frank-Raue","year":"2010","journal-title":"Hum Mutat"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)13_bib34","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1210\/jc.2005-0064","article-title":"Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2","volume":"90","author":"Machens","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)13_bib35","first-page":"91","article-title":"Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs a Calcitonine","volume":"83","author":"Schuffenecker","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)13_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/thy.2005.15.531","article-title":"RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors","volume":"15","author":"Kouvaraki","year":"2005","journal-title":"Thyroid"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222023997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222023997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-s1\/cln-67-s1-69.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:15:24Z","timestamp":1761722124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222023997"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322012001300013&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3328821\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":36,"alternative-id":["S1807593222023997"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(sup01)13","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotype-phenotype correlation in multiple endocrine neoplasia type 2","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(Sup01)13","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}